Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline
Global health aid agency Unitaid has written to Johnson & Johnson’s (J&J) CEO Joaquin Duato, urging him to take “immediate action” to expand access to the company’s tuberculosis drug bedaquiline.